Rising CMV PP65 antigenemia and DNA levels during preemptive antiviral therapy.
Boeckh
Michael
M
Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, Washington, USA. mboeckh@fhcrc.org.
D000956:Antigens, Viral / Q000097:blood*; D000998:Antiviral Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000821:virology; D004279:DNA, Viral / Q000097:blood; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D014184:Transplantation, Homologous; D019562:Viral Load; D014766:Viremia / Q000188:drug therapy* / Q000628:therapy
D000956:Antigens, Viral; D000998:Antiviral Agents; D004279:DNA, Viral